Anti-Müllerian hormone serum concentrations of women with germlineBRCA1orBRCA2mutations
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-Müllerian hormone serum concentrations of women with germlineBRCA1orBRCA2mutations
Authors
Keywords
-
Journal
HUMAN REPRODUCTION
Volume 31, Issue 5, Pages 1126-1132
Publisher
Oxford University Press (OUP)
Online
2016-04-20
DOI
10.1093/humrep/dew044
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-Müllerian Hormone and Lifestyle, Reproductive, and Environmental Factors Among Women in Rural South Africa
- (2015) Kristina W. Whitworth et al. EPIDEMIOLOGY
- Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool
- (2015) Richard A. Anderson et al. FERTILITY AND STERILITY
- What is the “ovarian reserve”?
- (2015) John K. Findlay et al. FERTILITY AND STERILITY
- Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair
- (2015) Felix R Day et al. NATURE GENETICS
- First fully automated immunoassay for anti-Müllerian hormone
- (2014) Dieter Gassner et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Amh values in reproductive aged women with and without the brca1 mutation
- (2014) M.E. Pavone et al. FERTILITY AND STERILITY
- BRCA1 germline mutations may be associated with reduced ovarian reserve
- (2014) Erica T. Wang et al. FERTILITY AND STERILITY
- Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response
- (2014) Stamatina Iliodromiti et al. HUMAN REPRODUCTION UPDATE
- BRCA Mutation Carriers Do Not Have Compromised Ovarian Reserve
- (2014) Rachel Michaelson-Cohen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Age-Related Decline in DNA Repair Function Explains Diminished Ovarian Reserve, Earlier Menopause, and Possible Oocyte Vulnerability to Chemotherapy in Women WithBRCAMutations
- (2014) Kutluk Oktay et al. JOURNAL OF CLINICAL ONCOLOGY
- Reversal of Female Infertility by Chk2 Ablation Reveals the Oocyte DNA Damage Checkpoint Pathway
- (2014) E. Bolcun-Filas et al. SCIENCE
- Comparison of age at natural menopause inBRCA1/2mutation carriers with a non-clinic-based sample of women in northern California
- (2013) Wayne T. Lin et al. CANCER
- Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation
- (2013) Amy Finch et al. FERTILITY AND STERILITY
- Reproductive and Lifestyle Determinants of Anti-Müllerian Hormone in a Large Population-based Study
- (2013) M. Dólleman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Can Anti-Müllerian Hormone Predict the Diagnosis of Polycystic Ovary Syndrome? A Systematic Review and Meta-Analysis of Extracted Data
- (2013) Stamatina Iliodromiti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Modeling Age at Menopause Using Serum Concentration of Anti-Mullerian Hormone
- (2013) Fahimeh Ramezani Tehrani et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Do BRCA1 and BRCA2 Mutation Carriers Have Earlier Natural Menopause Than Their Noncarrier Relatives? Results From the Kathleen Cuningham Foundation Consortium for Research Into Familial Breast Cancer
- (2013) Ian M. Collins et al. JOURNAL OF CLINICAL ONCOLOGY
- Impairment of BRCA1-Related DNA Double-Strand Break Repair Leads to Ovarian Aging in Mice and Humans
- (2013) S. Titus et al. Science Translational Medicine
- Impact of breast cancer on anti-mullerian hormone levels in young women
- (2012) H. I. Su et al. BREAST CANCER RESEARCH AND TREATMENT
- Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study
- (2012) Casper P. Hagen et al. FERTILITY AND STERILITY
- Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways
- (2012) Lisette Stolk et al. NATURE GENETICS
- Pretreatment Serum Anti-Müllerian Hormone Predicts Long-Term Ovarian Function and Bone Mass after Chemotherapy for Early Breast Cancer
- (2011) Richard A. Anderson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Anti-Müllerian Hormone Predicts Menopause: A Long-Term Follow-Up Study in Normoovulatory Women
- (2011) S. L. Broer et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Antimüllerian Hormone as a Predictor of Natural Fecundability in Women Aged 30–42 Years
- (2011) Anne Z. Steiner et al. OBSTETRICS AND GYNECOLOGY
- A Validated Model of Serum Anti-Müllerian Hormone from Conception to Menopause
- (2011) Thomas W. Kelsey et al. PLoS One
- Correlation of ovarian reserve tests with histologically determined primordial follicle number
- (2010) Karl R. Hansen et al. FERTILITY AND STERILITY
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
- (2010) Susan M. Domchek JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of BRCA1 Mutations With Occult Primary Ovarian Insufficiency: A Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks
- (2009) Kutluk Oktay et al. JOURNAL OF CLINICAL ONCOLOGY
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
- The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
- (2008) A C Antoniou et al. BRITISH JOURNAL OF CANCER
- Anti-Mullerian Hormone and Inhibin B in the Definition of Ovarian Aging and the Menopause Transition
- (2008) MaryFran R. Sowers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search